| Title |
Treating Idiopathic Pulmonary Fibrosis with the Addition of Co-Trimoxazole: An Economic Evaluation Alongside a Randomised Controlled Trial
|
|---|---|
| Published in |
PharmacoEconomics, December 2013
|
| DOI | 10.1007/s40273-013-0112-z |
| Pubmed ID | |
| Authors |
Edward C. F. Wilson, Ludmila Shulgina, Anthony P. Cahn, Edwin R. Chilvers, Helen Parfrey, Allan B. Clark, Orion P. Twentyman, Andrew M. Wilson |
| Abstract |
Idiopathic pulmonary fibrosis (IPF) is a fibrotic disease of the lungs of unknown origin with a poor prognosis. A small trial of co-trimoxazole demonstrated improvements in symptoms and functional parameters over a 3-month period. We therefore conducted a larger trial with a concurrent economic evaluation to investigate this antibiotic further. |
Mendeley readers
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 60 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 11 | 18% |
| Other | 9 | 15% |
| Student > Doctoral Student | 8 | 13% |
| Researcher | 7 | 12% |
| Student > Ph. D. Student | 5 | 8% |
| Other | 5 | 8% |
| Unknown | 15 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 24 | 40% |
| Nursing and Health Professions | 4 | 7% |
| Business, Management and Accounting | 2 | 3% |
| Agricultural and Biological Sciences | 2 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Other | 9 | 15% |
| Unknown | 17 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2017.
All research outputs
#7,436,181
of 22,733,113 outputs
Outputs from PharmacoEconomics
#843
of 1,815 outputs
Outputs of similar age
#92,214
of 306,889 outputs
Outputs of similar age from PharmacoEconomics
#10
of 21 outputs
Altmetric has tracked 22,733,113 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,815 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 306,889 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.